Cargando…
High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
Approximately 25% of all patients with stage II colorectal cancer will experience recurrent disease and subsequently die within 5 years. MicroRNA-21 (miR-21) is upregulated in several cancer types and has been associated with survival in colon cancer. In the present study we developed a robust in si...
Autores principales: | Nielsen, Boye Schnack, Jørgensen, Stine, Fog, Jacob Ulrik, Søkilde, Rolf, Christensen, Ib Jarle, Hansen, Ulla, Brünner, Nils, Baker, Adam, Møller, Søren, Nielsen, Hans Jørgen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998639/ https://www.ncbi.nlm.nih.gov/pubmed/21069438 http://dx.doi.org/10.1007/s10585-010-9355-7 |
Ejemplares similares
-
Data fusion in metabolomic cancer diagnostics
por: Bro, Rasmus, et al.
Publicado: (2012) -
Early Detection and Recurrence of Colorectal Adenomas by Combination of Eight Cancer-Associated Biomarkers in Plasma
por: Rasmussen, Louise, et al.
Publicado: (2020) -
An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort
por: Smith, David Hersi, et al.
Publicado: (2013) -
Cathepsin X in serum from patients with colorectal cancer: relation to prognosis
por: Vizin, Tjasa, et al.
Publicado: (2012) -
miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer
por: Nielsen, Boye Schnack, et al.
Publicado: (2014)